April 2 (Reuters) - TC BioPharm Ltd :
* TCBP INCREASING TREATMENT CAPACITY WITH EXPANDED MANUFACTURING PROCESS
* TC BIOPHARM LTD: UNDERTAKING, WHICH WILL UTILIZE ITS CURRENT INFRASTRUCTURE, WILL PROVIDE A COST REDUCTION OF 85% PER PATIENT TREATMENT
* TC BIOPHARM LTD: EXPECTS TO IMPLEMENT IMPROVED MANUFACTURE PROCESS INTO ITS CURRENT FACILITY IN NEXT 24 MONTHS
* TC BIOPHARM: DEVELOPING STREAMLINED,SCALED-UP MANUFACTURING PROCESS TO INCREASE TREATMENTS CAPACITY FROM 52 PATIENT TREATMENTS/YEAR TO MORE THAN 1,000
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments